SecBot SecBot
S-3 ·Filed Apr 15, 2026

WGRX

Wellgistics Health, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001493152-26-016876
Shelf registration — potential dilution
Actionable Insight • Neutral

Monitor for future prospectus supplements that will disclose specific terms of any offering. The large size relative to market cap suggests any actual offering could be significantly dilutive. Watch for insider selling patterns as the shelf becomes effective.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
WGRX ▼ -60.49% at T+60d
NEUTRAL call -60.49% · α vs SPY -67.53% · entry $7.37 → $2.91
Entry = T+0 close
Apr 15, 2026
via day close
T+1d
-2.24%
call -2.24% · α -3.46%
$7.20
settled 6mo ago
T+5d
-7.88%
call -7.88% · α -8.86%
$6.79
settled 6mo ago
T+20d
-36.18%
call -36.18% · α -42.82%
$4.70
settled 6mo ago
T+60d
-60.49%
call -60.49% · α -67.53%
$2.91
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Wellgistics Health (WGRX) filed a shelf registration (S-3) to potentially raise up to $200 million through future offerings of common stock, preferred stock, debt securities, warrants, rights, or units. This is a routine capital markets filing that does not immediately raise capital but signals potential future dilution.

Key Financial Metrics

Offering Size
$200.0M

Key Facts

  • Wellgistics Health filed an S-3 shelf registration to potentially offer up to $200,000,000 of securities
  • Securities may include common stock, preferred stock, debt, warrants, rights, or units
  • No immediate capital raise; this is a preparatory filing for potential future offerings
  • Company has a market cap of $17 million, making the $200 million shelf size highly dilutive if fully utilized
  • Recent financings include convertible notes totaling $9.625 million in aggregate principal

Financial Impact

Potential dilution of up to 1,176% of current market cap if full $200 million shelf is used

dilutionmarket capshare priceequity

Risk Factors

  • Significant dilution if the company draws down on the shelf
  • Potential for low-priced offerings that could depress share price
  • Company may issue securities at inopportune times

Market Snapshot

Exchange
Nasdaq
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001493152-26-016876
Exhibit: ex107.htm0001493152-26-016876
Exhibit: ex5-1.htm0001493152-26-016876
Exhibit: ex23-1.htm0001493152-26-016876
Document: 0001493152-26-016876-index-headers.html0001493152-26-016876
Document: 0001493152-26-016876-index.html0001493152-26-016876
Document: 0001493152-26-016876.txt0001493152-26-016876
12 reports for WGRX
Performance horizon
75% Hit rate @ T+20 3 of 4 directional calls Went positive at some point 4 of 4 best @ T+60▲ +52.70%Apr 7, 2026
Filters
Rows
Reports for WGRX — sortable, filterable
TypeNow
Oct 9, 2026
17d ago
S-1/A
BEARISH ★ 7/10
—awaiting T+20——
May 29, 2026
21w ago
8-K
BEARISH ★ 8/10
$3.85 $3.10▲ +19.48%▲ +18.18%—
May 21, 2026
22w ago
8-K
MIXED ★ 7/10
$5.35 $3.18▼ −40.52%▼ −40.85%—
May 19, 2026
22w ago
8-K
MIXED ★ 6/10
$6.45 $3.39▼ −47.44%▼ −48.18%—
May 19, 2026
22w ago
8-K
NEUTRAL ★ 2/10
$8.40 $3.70▼ −55.95%▼ −56.94%—
May 18, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$8.70 $3.69▼ −57.59%▼ −59.17%—
May 8, 2026
24w ago
EFFECT
BEARISH ★ 6/10
$4.21 $4.35▼ −3.33%▼ −3.30%—
Apr 24, 2026
26w ago
10-K/A
BEARISH ★ 7/10
$6.23 $3.82▲ +38.68%▲ +43.64%—
Apr 17, 2026
27w ago
8-K
NEUTRAL ★ 5/10
$6.60 $8.70▲ +31.82%▲ +27.62%—
Apr 15, 2026
27w ago
S-3
NEUTRAL ★ 3/10
$7.37 $4.70▼ −36.18%▼ −42.82%—
Showing 10 of 12

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 15, 2026